

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.73070152 |
| 2 | viral transcription (GO:0019083) | 6.49726309 |
| 3 | translational termination (GO:0006415) | 6.37899775 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 6.05869732 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.68961794 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 5.59126735 |
| 7 | protein targeting to ER (GO:0045047) | 5.54791915 |
| 8 | translational elongation (GO:0006414) | 5.49972300 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 5.29563081 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.26994836 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.21262070 |
| 12 | viral life cycle (GO:0019058) | 5.03051713 |
| 13 | cellular protein complex disassembly (GO:0043624) | 4.95872150 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.91741887 |
| 15 | translational initiation (GO:0006413) | 4.87778567 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 4.36557690 |
| 17 | protein complex disassembly (GO:0043241) | 4.34675989 |
| 18 | protein targeting to Golgi (GO:0000042) | 4.17050268 |
| 19 | formation of translation preinitiation complex (GO:0001731) | 4.13029737 |
| 20 | macromolecular complex disassembly (GO:0032984) | 4.10705117 |
| 21 | establishment of protein localization to Golgi (GO:0072600) | 4.07715575 |
| 22 | DNA unwinding involved in DNA replication (GO:0006268) | 4.01123194 |
| 23 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.00752231 |
| 24 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96462215 |
| 25 | translation (GO:0006412) | 3.95317663 |
| 26 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.85731854 |
| 27 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.82656258 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81053469 |
| 29 | DNA strand elongation (GO:0022616) | 3.80282904 |
| 30 | ether lipid metabolic process (GO:0046485) | 3.78777153 |
| 31 | cellular response to ethanol (GO:0071361) | 3.76246813 |
| 32 | definitive hemopoiesis (GO:0060216) | 3.71351112 |
| 33 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.71148949 |
| 34 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.71063990 |
| 35 | protein targeting to membrane (GO:0006612) | 3.67096480 |
| 36 | DNA deamination (GO:0045006) | 3.59295076 |
| 37 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.55624244 |
| 38 | regulation of germinal center formation (GO:0002634) | 3.54637010 |
| 39 | telomere maintenance via recombination (GO:0000722) | 3.53599016 |
| 40 | mRNA catabolic process (GO:0006402) | 3.50242080 |
| 41 | establishment of integrated proviral latency (GO:0075713) | 3.44598052 |
| 42 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.43669679 |
| 43 | DNA replication initiation (GO:0006270) | 3.42455999 |
| 44 | regulation of hypersensitivity (GO:0002883) | 3.41333124 |
| 45 | mitotic recombination (GO:0006312) | 3.41295196 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.34721613 |
| 47 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.32156245 |
| 48 | RNA catabolic process (GO:0006401) | 3.31284270 |
| 49 | early endosome to late endosome transport (GO:0045022) | 3.29505489 |
| 50 | carnitine transport (GO:0015879) | 3.21386716 |
| 51 | amino-acid betaine transport (GO:0015838) | 3.21386716 |
| 52 | CENP-A containing nucleosome assembly (GO:0034080) | 3.19501597 |
| 53 | protein prenylation (GO:0018342) | 3.19220565 |
| 54 | prenylation (GO:0097354) | 3.19220565 |
| 55 | carnitine transmembrane transport (GO:1902603) | 3.17857418 |
| 56 | activated T cell proliferation (GO:0050798) | 3.17136560 |
| 57 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.16275454 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.14817106 |
| 59 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13132901 |
| 60 | regulation of pigment cell differentiation (GO:0050932) | 3.10481983 |
| 61 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.09421524 |
| 62 | intracellular lipid transport (GO:0032365) | 3.08817187 |
| 63 | chromatin remodeling at centromere (GO:0031055) | 3.08114297 |
| 64 | rRNA processing (GO:0006364) | 3.07676755 |
| 65 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.05999895 |
| 66 | telomere maintenance via telomere lengthening (GO:0010833) | 3.05407959 |
| 67 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.04430032 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.03441187 |
| 69 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.02473693 |
| 70 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.02436588 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.01110925 |
| 72 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.01031041 |
| 73 | positive regulation of muscle hypertrophy (GO:0014742) | 3.01031041 |
| 74 | positive regulation of mast cell degranulation (GO:0043306) | 2.99430502 |
| 75 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.99430502 |
| 76 | cellular component biogenesis (GO:0044085) | 2.98232243 |
| 77 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97534829 |
| 78 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97534829 |
| 79 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95983909 |
| 80 | cell differentiation involved in metanephros development (GO:0072202) | 2.95632270 |
| 81 | kinetochore organization (GO:0051383) | 2.94652605 |
| 82 | positive regulation of digestive system process (GO:0060456) | 2.92913711 |
| 83 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.92585476 |
| 84 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.92585476 |
| 85 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.92585476 |
| 86 | rRNA metabolic process (GO:0016072) | 2.90364599 |
| 87 | tachykinin receptor signaling pathway (GO:0007217) | 2.89726317 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89643055 |
| 89 | relaxation of cardiac muscle (GO:0055119) | 2.89361173 |
| 90 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.89270261 |
| 91 | regulation of relaxation of muscle (GO:1901077) | 2.88235019 |
| 92 | establishment of viral latency (GO:0019043) | 2.85278334 |
| 93 | spliceosomal snRNP assembly (GO:0000387) | 2.84909699 |
| 94 | DNA damage response, detection of DNA damage (GO:0042769) | 2.84590509 |
| 95 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.84396183 |
| 96 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.84396183 |
| 97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83802564 |
| 98 | flavonoid metabolic process (GO:0009812) | 2.83673704 |
| 99 | mRNA modification (GO:0016556) | 2.83220207 |
| 100 | regulation of protein glycosylation (GO:0060049) | 2.81955515 |
| 101 | relaxation of smooth muscle (GO:0044557) | 2.81627771 |
| 102 | nerve growth factor signaling pathway (GO:0038180) | 2.80524701 |
| 103 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.79999611 |
| 104 | protein targeting to vacuole (GO:0006623) | 2.79877147 |
| 105 | protein targeting to lysosome (GO:0006622) | 2.79877147 |
| 106 | establishment of protein localization to vacuole (GO:0072666) | 2.79877147 |
| 107 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.79191335 |
| 108 | nucleobase biosynthetic process (GO:0046112) | 2.78738589 |
| 109 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.78667260 |
| 110 | negative regulation of ligase activity (GO:0051352) | 2.78667260 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.78663141 |
| 112 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.78187673 |
| 113 | thrombin receptor signaling pathway (GO:0070493) | 2.78164364 |
| 114 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.78117806 |
| 115 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.77714352 |
| 116 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77090277 |
| 117 | cellular glucuronidation (GO:0052695) | 2.76440388 |
| 118 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76248142 |
| 119 | relaxation of muscle (GO:0090075) | 2.75211694 |
| 120 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.75087577 |
| 121 | regulation of platelet aggregation (GO:0090330) | 2.74614359 |
| 122 | inositol phosphate catabolic process (GO:0071545) | 2.73485366 |
| 123 | regulation of sarcomere organization (GO:0060297) | 2.73129501 |
| 124 | protein localization to Golgi apparatus (GO:0034067) | 2.71697976 |
| 125 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.71451969 |
| 126 | DNA replication checkpoint (GO:0000076) | 2.70583135 |
| 127 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.70076142 |
| 128 | viral mRNA export from host cell nucleus (GO:0046784) | 2.68721320 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67772183 |
| 130 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.66144961 |
| 131 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.65568343 |
| 132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.64987786 |
| 133 | ATP synthesis coupled proton transport (GO:0015986) | 2.64763431 |
| 134 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.64763431 |
| 135 | Golgi to endosome transport (GO:0006895) | 2.64546142 |
| 136 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.64244542 |
| 137 | purine nucleobase biosynthetic process (GO:0009113) | 2.64020307 |
| 138 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.63936508 |
| 139 | glucuronate metabolic process (GO:0019585) | 2.62601658 |
| 140 | uronic acid metabolic process (GO:0006063) | 2.62601658 |
| 141 | lipid translocation (GO:0034204) | 2.62510019 |
| 142 | phospholipid translocation (GO:0045332) | 2.62510019 |
| 143 | negative T cell selection (GO:0043383) | 2.62470280 |
| 144 | IMP biosynthetic process (GO:0006188) | 2.62283777 |
| 145 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61150231 |
| 146 | spliceosomal complex assembly (GO:0000245) | 2.60913872 |
| 147 | cell cycle G1/S phase transition (GO:0044843) | 2.60230674 |
| 148 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.60230674 |
| 149 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.60172744 |
| 150 | DNA replication-independent nucleosome organization (GO:0034724) | 2.60172744 |
| 151 | polyol catabolic process (GO:0046174) | 2.60118038 |
| 152 | pseudouridine synthesis (GO:0001522) | 2.59917198 |
| 153 | endothelium development (GO:0003158) | 2.59632582 |
| 154 | IMP metabolic process (GO:0046040) | 2.59517363 |
| 155 | megakaryocyte development (GO:0035855) | 2.58887735 |
| 156 | positive regulation of mast cell activation (GO:0033005) | 2.58842055 |
| 157 | adenosine metabolic process (GO:0046085) | 2.57325100 |
| 158 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57215886 |
| 159 | secondary heart field specification (GO:0003139) | 2.55671649 |
| 160 | heart field specification (GO:0003128) | 2.55671649 |
| 161 | ribosome biogenesis (GO:0042254) | 2.54972496 |
| 162 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.54695733 |
| 163 | positive regulation of vasculogenesis (GO:2001214) | 2.54644900 |
| 164 | GTP biosynthetic process (GO:0006183) | 2.54095503 |
| 165 | protein localization to kinetochore (GO:0034501) | 2.53874442 |
| 166 | proteasome assembly (GO:0043248) | 2.53160239 |
| 167 | histone mRNA metabolic process (GO:0008334) | 2.53101683 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 2.52944976 |
| 169 | platelet dense granule organization (GO:0060155) | 2.52536508 |
| 170 | UTP biosynthetic process (GO:0006228) | 2.52445824 |
| 171 | negative regulation of cell killing (GO:0031342) | 2.51782772 |
| 172 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.51782772 |
| 173 | positive regulation of glycolytic process (GO:0045821) | 2.51754023 |
| 174 | membrane budding (GO:0006900) | 2.50878040 |
| 175 | positive regulation of cell cycle arrest (GO:0071158) | 2.49942918 |
| 176 | negative regulation of adaptive immune response (GO:0002820) | 2.48777622 |
| 177 | DNA ligation (GO:0006266) | 2.46862463 |
| 178 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.46613073 |
| 179 | regulation of B cell differentiation (GO:0045577) | 2.46529042 |
| 180 | positive regulation of B cell differentiation (GO:0045579) | 2.45916036 |
| 181 | telomere organization (GO:0032200) | 2.45332316 |
| 182 | B cell receptor signaling pathway (GO:0050853) | 2.44968026 |
| 183 | succinate metabolic process (GO:0006105) | 2.44960598 |
| 184 | inositol phosphate dephosphorylation (GO:0046855) | 2.44398315 |
| 185 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.44398315 |
| 186 | angiotensin maturation (GO:0002003) | 2.43918322 |
| 187 | ncRNA 3-end processing (GO:0043628) | 2.43809888 |
| 188 | peroxisome fission (GO:0016559) | 2.42766258 |
| 189 | nucleoside diphosphate catabolic process (GO:0009134) | 2.41963875 |
| 190 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.40012795 |
| 191 | dendritic cell migration (GO:0036336) | 2.39400107 |
| 192 | regulation of vasculogenesis (GO:2001212) | 2.38923457 |
| 193 | carnitine shuttle (GO:0006853) | 2.37966735 |
| 194 | dentate gyrus development (GO:0021542) | 2.37086354 |
| 195 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35031773 |
| 196 | detection of other organism (GO:0098543) | 2.34355802 |
| 197 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.34244103 |
| 198 | cellular extravasation (GO:0045123) | 2.33472721 |
| 199 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.33444771 |
| 200 | production of molecular mediator of immune response (GO:0002440) | 2.32887991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.84656931 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.39394964 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.82734933 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.65979999 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.24068278 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18218632 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.13500007 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.07436067 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.03928436 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.91730969 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.78669584 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.77848738 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.77198232 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.73818128 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.71122496 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.63111151 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59203918 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57258638 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.55801031 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.55612182 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 2.52601190 |
| 22 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.49466662 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.40777509 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.40057460 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.39649062 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.34720357 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34600306 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.33575634 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.30973772 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29224272 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.28050110 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.24070923 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.17613189 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17177468 |
| 35 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.15595717 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15319941 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14264316 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11297813 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.09705737 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.08626824 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.07481654 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.04281774 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.95994838 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93724483 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.92508080 |
| 46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.91810926 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.89907520 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.86050179 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85985488 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84485267 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82779405 |
| 52 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.82004668 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80009539 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79550300 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76749363 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76644386 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75043515 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.72272364 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70212682 |
| 60 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.69012778 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.68990350 |
| 62 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68255667 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67454510 |
| 64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66070429 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63669564 |
| 66 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63402833 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.62381224 |
| 68 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.62207477 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60997325 |
| 70 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.60904468 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60678770 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60625268 |
| 73 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58512878 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.57526911 |
| 75 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57154942 |
| 76 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56904277 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56481003 |
| 78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.55586044 |
| 79 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53906520 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52157229 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.51705265 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50770460 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48287980 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.46474334 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.46382990 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46268144 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.45420925 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44951192 |
| 89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.44635793 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.44306097 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.43823263 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.43589391 |
| 93 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43356830 |
| 94 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.42835343 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39589024 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39527239 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39410032 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.38942712 |
| 99 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.38867140 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38568965 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38174099 |
| 102 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.38134305 |
| 103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37717024 |
| 104 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.37586946 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36603374 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36206966 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34777843 |
| 108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34111930 |
| 109 | MYC_22102868_ChIP-Seq_BL_Human | 1.33474306 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32172838 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.31235418 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29263831 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28162287 |
| 114 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.28022487 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27882294 |
| 116 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.27628594 |
| 117 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27105606 |
| 118 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.27022769 |
| 119 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26935359 |
| 120 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25541461 |
| 121 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25246325 |
| 122 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25056210 |
| 123 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24893813 |
| 124 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.24870125 |
| 125 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24725548 |
| 126 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.24373622 |
| 127 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23891358 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.22971934 |
| 129 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22817597 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22804244 |
| 131 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22311787 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21968822 |
| 133 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21422548 |
| 134 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21415170 |
| 135 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.20015949 |
| 136 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19495592 |
| 137 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19464072 |
| 138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19360345 |
| 139 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19360345 |
| 140 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19154689 |
| 141 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18745777 |
| 142 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18650697 |
| 143 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18633405 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.18585101 |
| 145 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16424898 |
| 146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14727356 |
| 147 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.14623091 |
| 148 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14623091 |
| 149 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14006236 |
| 150 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13692735 |
| 151 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12773293 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12740231 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12740231 |
| 154 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11556328 |
| 155 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08757403 |
| 156 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08003453 |
| 157 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07846421 |
| 158 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07692612 |
| 159 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07548565 |
| 160 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07365518 |
| 161 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07357039 |
| 162 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07140447 |
| 163 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06999305 |
| 164 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.06946968 |
| 165 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06895006 |
| 166 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06351038 |
| 167 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05794728 |
| 168 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05697813 |
| 169 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05206735 |
| 170 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.04762826 |
| 171 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03721863 |
| 172 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.03402926 |
| 173 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03129162 |
| 174 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02634888 |
| 175 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01700043 |
| 176 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00849230 |
| 177 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99341058 |
| 178 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96850486 |
| 179 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96340326 |
| 180 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96219725 |
| 181 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94431963 |
| 182 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93702132 |
| 183 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92637693 |
| 184 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91188528 |
| 185 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90711492 |
| 186 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90504095 |
| 187 | MYB_26560356_Chip-Seq_TH2_Human | 0.90089511 |
| 188 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89872479 |
| 189 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89700600 |
| 190 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89036396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.80965417 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.89998483 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.85987629 |
| 4 | MP0002009_preneoplasia | 3.67230848 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.17343877 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.75071487 |
| 7 | MP0004147_increased_porphyrin_level | 2.65647945 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.63510363 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.57504917 |
| 10 | MP0003077_abnormal_cell_cycle | 2.55014465 |
| 11 | MP0006054_spinal_hemorrhage | 2.49926541 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.46491624 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.45808022 |
| 14 | MP0004043_abnormal_pH_regulation | 2.40452403 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.31658363 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.22692477 |
| 17 | MP0004484_altered_response_of | 2.19445440 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.16848797 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.15101688 |
| 20 | MP0008057_abnormal_DNA_replication | 2.14359757 |
| 21 | MP0003880_abnormal_central_pattern | 2.12652358 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.11172621 |
| 23 | MP0003111_abnormal_nucleus_morphology | 2.04324005 |
| 24 | MP0001986_abnormal_taste_sensitivity | 2.00376217 |
| 25 | MP0008058_abnormal_DNA_repair | 1.86036815 |
| 26 | MP0000490_abnormal_crypts_of | 1.85830266 |
| 27 | MP0009785_altered_susceptibility_to | 1.82866915 |
| 28 | MP0002132_abnormal_respiratory_system | 1.79694552 |
| 29 | MP0008932_abnormal_embryonic_tissue | 1.73029496 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.69759328 |
| 31 | MP0003186_abnormal_redox_activity | 1.68586694 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.62056087 |
| 33 | MP0001188_hyperpigmentation | 1.62048371 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.61682874 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.56684659 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.55299456 |
| 37 | MP0003436_decreased_susceptibility_to | 1.51921900 |
| 38 | MP0003941_abnormal_skin_development | 1.49496033 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.48858756 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.48636839 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.47617023 |
| 42 | MP0001853_heart_inflammation | 1.46370534 |
| 43 | MP0003828_pulmonary_edema | 1.46096443 |
| 44 | MP0002398_abnormal_bone_marrow | 1.44070078 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.44002418 |
| 46 | MP0001800_abnormal_humoral_immune | 1.43722046 |
| 47 | MP0000858_altered_metastatic_potential | 1.41626061 |
| 48 | MP0005025_abnormal_response_to | 1.41240457 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.41059087 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.41003396 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.40611819 |
| 52 | MP0003195_calcinosis | 1.39574845 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.38092129 |
| 54 | MP0001819_abnormal_immune_cell | 1.37926917 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.37851707 |
| 56 | MP0002722_abnormal_immune_system | 1.35947656 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.34929457 |
| 58 | MP0002405_respiratory_system_inflammati | 1.34549950 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.34378873 |
| 60 | MP0001730_embryonic_growth_arrest | 1.33045300 |
| 61 | MP0001851_eye_inflammation | 1.32855878 |
| 62 | MP0009697_abnormal_copulation | 1.32418828 |
| 63 | MP0004885_abnormal_endolymph | 1.31615944 |
| 64 | MP0000685_abnormal_immune_system | 1.30920010 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.29287650 |
| 66 | MP0005671_abnormal_response_to | 1.29006506 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.27590432 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.26896750 |
| 69 | MP0002723_abnormal_immune_serum | 1.25742500 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.25462252 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.24692892 |
| 72 | MP0010030_abnormal_orbit_morphology | 1.23494096 |
| 73 | MP0003252_abnormal_bile_duct | 1.22685403 |
| 74 | MP0001664_abnormal_digestion | 1.22584616 |
| 75 | MP0003866_abnormal_defecation | 1.22537141 |
| 76 | MP0000716_abnormal_immune_system | 1.22076988 |
| 77 | MP0002429_abnormal_blood_cell | 1.20222481 |
| 78 | MP0003786_premature_aging | 1.18861083 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.18329901 |
| 80 | MP0002006_tumorigenesis | 1.17877535 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.17224762 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.17115078 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 1.15537715 |
| 84 | MP0000427_abnormal_hair_cycle | 1.15241507 |
| 85 | MP0000313_abnormal_cell_death | 1.15086784 |
| 86 | MP0010368_abnormal_lymphatic_system | 1.14591366 |
| 87 | MP0003045_fibrosis | 1.10926493 |
| 88 | MP0002876_abnormal_thyroid_physiology | 1.10030574 |
| 89 | MP0001545_abnormal_hematopoietic_system | 1.09498787 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 1.09498787 |
| 91 | MP0004130_abnormal_muscle_cell | 1.07646288 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 1.07299287 |
| 93 | MP0005360_urolithiasis | 1.06847533 |
| 94 | MP0005535_abnormal_body_temperature | 1.06378006 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 1.06064794 |
| 96 | MP0005023_abnormal_wound_healing | 1.05029067 |
| 97 | MP0002419_abnormal_innate_immunity | 1.03222792 |
| 98 | MP0002796_impaired_skin_barrier | 1.03070927 |
| 99 | MP0002938_white_spotting | 1.02734951 |
| 100 | MP0008004_abnormal_stomach_pH | 1.01357009 |
| 101 | MP0005408_hypopigmentation | 0.99991221 |
| 102 | MP0001697_abnormal_embryo_size | 0.98538638 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.97998894 |
| 104 | MP0009053_abnormal_anal_canal | 0.97414000 |
| 105 | MP0004883_abnormal_blood_vessel | 0.96870940 |
| 106 | MP0005501_abnormal_skin_physiology | 0.96003911 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.95865456 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.95865456 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.93660513 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.91521767 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.91045397 |
| 112 | MP0002080_prenatal_lethality | 0.91017493 |
| 113 | MP0000537_abnormal_urethra_morphology | 0.90930514 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90567415 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.90146579 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.89467235 |
| 117 | MP0003724_increased_susceptibility_to | 0.89363472 |
| 118 | MP0001790_abnormal_immune_system | 0.88942648 |
| 119 | MP0005387_immune_system_phenotype | 0.88942648 |
| 120 | MP0002060_abnormal_skin_morphology | 0.88888439 |
| 121 | MP0000372_irregular_coat_pigmentation | 0.88208352 |
| 122 | MP0001764_abnormal_homeostasis | 0.86404245 |
| 123 | MP0005365_abnormal_bile_salt | 0.86389916 |
| 124 | MP0005075_abnormal_melanosome_morpholog | 0.86079996 |
| 125 | MP0005275_abnormal_skin_tensile | 0.85820651 |
| 126 | MP0004134_abnormal_chest_morphology | 0.85355674 |
| 127 | MP0005380_embryogenesis_phenotype | 0.85264175 |
| 128 | MP0001672_abnormal_embryogenesis/_devel | 0.85264175 |
| 129 | MP0001873_stomach_inflammation | 0.85240049 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.85161799 |
| 131 | MP0003984_embryonic_growth_retardation | 0.84948511 |
| 132 | MP0002088_abnormal_embryonic_growth/wei | 0.84523065 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.83940240 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.82521877 |
| 135 | MP0001915_intracranial_hemorrhage | 0.81947164 |
| 136 | MP0005166_decreased_susceptibility_to | 0.81577878 |
| 137 | MP0005332_abnormal_amino_acid | 0.80850553 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.80747634 |
| 139 | MP0010307_abnormal_tumor_latency | 0.80449754 |
| 140 | MP0008995_early_reproductive_senescence | 0.80200762 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.79509261 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.79223991 |
| 143 | MP0003448_altered_tumor_morphology | 0.78918297 |
| 144 | MP0000343_altered_response_to | 0.77755968 |
| 145 | MP0003183_abnormal_peptide_metabolism | 0.77599960 |
| 146 | MP0005388_respiratory_system_phenotype | 0.77538267 |
| 147 | MP0002133_abnormal_respiratory_system | 0.77538267 |
| 148 | MP0001666_abnormal_nutrient_absorption | 0.77494065 |
| 149 | MP0001486_abnormal_startle_reflex | 0.75882562 |
| 150 | MP0001191_abnormal_skin_condition | 0.74911061 |
| 151 | MP0001243_abnormal_dermal_layer | 0.73388516 |
| 152 | MP0002127_abnormal_cardiovascular_syste | 0.73193922 |
| 153 | MP0001293_anophthalmia | 0.72755794 |
| 154 | MP0004947_skin_inflammation | 0.72204800 |
| 155 | MP0002086_abnormal_extraembryonic_tissu | 0.71172788 |
| 156 | MP0000377_abnormal_hair_follicle | 0.71040549 |
| 157 | MP0005266_abnormal_metabolism | 0.70249048 |
| 158 | MP0005551_abnormal_eye_electrophysiolog | 0.69972460 |
| 159 | MP0004197_abnormal_fetal_growth/weight/ | 0.69037557 |
| 160 | MP0000383_abnormal_hair_follicle | 0.68042637 |
| 161 | MP0010329_abnormal_lipoprotein_level | 0.65207566 |
| 162 | MP0005620_abnormal_muscle_contractility | 0.64381531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 5.71417685 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.30038870 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.82480446 |
| 4 | Thrombocytosis (HP:0001894) | 3.87312029 |
| 5 | Central scotoma (HP:0000603) | 3.76008828 |
| 6 | Macrocytic anemia (HP:0001972) | 3.73516244 |
| 7 | Papilledema (HP:0001085) | 3.67303601 |
| 8 | Pallor (HP:0000980) | 3.63368251 |
| 9 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.38683385 |
| 10 | Aplastic anemia (HP:0001915) | 3.19584223 |
| 11 | Colon cancer (HP:0003003) | 3.17486375 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15402269 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.14274556 |
| 14 | IgM deficiency (HP:0002850) | 3.14123919 |
| 15 | Renal cortical cysts (HP:0000803) | 3.07857193 |
| 16 | Abnormality of macular pigmentation (HP:0008002) | 3.07327861 |
| 17 | Papillary thyroid carcinoma (HP:0002895) | 3.03969292 |
| 18 | 11 pairs of ribs (HP:0000878) | 3.02965968 |
| 19 | Exertional dyspnea (HP:0002875) | 2.93334255 |
| 20 | Stomach cancer (HP:0012126) | 2.91684790 |
| 21 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.87259774 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86338959 |
| 23 | Abnormality of glycolysis (HP:0004366) | 2.75627765 |
| 24 | Increased serum pyruvate (HP:0003542) | 2.75627765 |
| 25 | Mitochondrial inheritance (HP:0001427) | 2.74125146 |
| 26 | Abnormal hemoglobin (HP:0011902) | 2.70336629 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.67126443 |
| 28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.67126443 |
| 29 | Acute myeloid leukemia (HP:0004808) | 2.66056957 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65377326 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65377326 |
| 32 | Albinism (HP:0001022) | 2.63296895 |
| 33 | Metabolic alkalosis (HP:0200114) | 2.62811065 |
| 34 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.61472237 |
| 35 | Myositis (HP:0100614) | 2.59692317 |
| 36 | Abnormality of vitamin B metabolism (HP:0004340) | 2.54173449 |
| 37 | Abnormality of cochlea (HP:0000375) | 2.52650253 |
| 38 | Volvulus (HP:0002580) | 2.49707576 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.49049972 |
| 40 | Rough bone trabeculation (HP:0100670) | 2.48431900 |
| 41 | Increased CSF lactate (HP:0002490) | 2.47857995 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.46826984 |
| 43 | Pheochromocytoma (HP:0002666) | 2.46245049 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.46141058 |
| 45 | Thyroiditis (HP:0100646) | 2.45876931 |
| 46 | Respiratory difficulties (HP:0002880) | 2.44284979 |
| 47 | T lymphocytopenia (HP:0005403) | 2.44205754 |
| 48 | Sudden death (HP:0001699) | 2.43967900 |
| 49 | Acute necrotizing encephalopathy (HP:0006965) | 2.42760452 |
| 50 | Hypothermia (HP:0002045) | 2.41969898 |
| 51 | Conjunctival hamartoma (HP:0100780) | 2.41593750 |
| 52 | Facial diplegia (HP:0001349) | 2.40268256 |
| 53 | Thyroid carcinoma (HP:0002890) | 2.39975920 |
| 54 | Calf muscle hypertrophy (HP:0008981) | 2.39715413 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.38965772 |
| 56 | Scotoma (HP:0000575) | 2.38912695 |
| 57 | Febrile seizures (HP:0002373) | 2.38204237 |
| 58 | Oral leukoplakia (HP:0002745) | 2.37850062 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.34649718 |
| 60 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.34160833 |
| 61 | Xerostomia (HP:0000217) | 2.33869096 |
| 62 | Microretrognathia (HP:0000308) | 2.33421795 |
| 63 | Premature graying of hair (HP:0002216) | 2.32626648 |
| 64 | Birth length less than 3rd percentile (HP:0003561) | 2.32134933 |
| 65 | Recurrent skin infections (HP:0001581) | 2.31654916 |
| 66 | Increased serum lactate (HP:0002151) | 2.30970174 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.30637817 |
| 68 | Abnormality of B cell number (HP:0010975) | 2.29235832 |
| 69 | B lymphocytopenia (HP:0010976) | 2.29235832 |
| 70 | Neuroendocrine neoplasm (HP:0100634) | 2.27095348 |
| 71 | Atonic seizures (HP:0010819) | 2.26363139 |
| 72 | Hepatic necrosis (HP:0002605) | 2.25847033 |
| 73 | Neoplasm of the small intestine (HP:0100833) | 2.24274516 |
| 74 | Abnormality of methionine metabolism (HP:0010901) | 2.24062345 |
| 75 | Subaortic stenosis (HP:0001682) | 2.23090354 |
| 76 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.23090354 |
| 77 | Abnormality of the anterior horn cell (HP:0006802) | 2.22114612 |
| 78 | Degeneration of anterior horn cells (HP:0002398) | 2.22114612 |
| 79 | Lymphoma (HP:0002665) | 2.21454954 |
| 80 | Acute lymphatic leukemia (HP:0006721) | 2.20532062 |
| 81 | Congenital stationary night blindness (HP:0007642) | 2.20130800 |
| 82 | Recurrent abscess formation (HP:0002722) | 2.19644194 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.19501226 |
| 84 | Congenital, generalized hypertrichosis (HP:0004540) | 2.19407946 |
| 85 | Chronic diarrhea (HP:0002028) | 2.19305842 |
| 86 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.19101809 |
| 87 | Palpitations (HP:0001962) | 2.18840719 |
| 88 | Abnormality of the preputium (HP:0100587) | 2.16953769 |
| 89 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16666782 |
| 90 | Renal Fanconi syndrome (HP:0001994) | 2.16666546 |
| 91 | Abnormality of chromosome stability (HP:0003220) | 2.16036959 |
| 92 | Biliary tract neoplasm (HP:0100574) | 2.14979264 |
| 93 | Abnormality of secondary sexual hair (HP:0009888) | 2.13849693 |
| 94 | Abnormality of the axillary hair (HP:0100134) | 2.13849693 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13102357 |
| 96 | Myelodysplasia (HP:0002863) | 2.12244457 |
| 97 | Eczematoid dermatitis (HP:0000976) | 2.10717259 |
| 98 | Abnormal biliary tract morphology (HP:0012440) | 2.09859368 |
| 99 | Disinhibition (HP:0000734) | 2.09374157 |
| 100 | Chronic otitis media (HP:0000389) | 2.09192225 |
| 101 | Recurrent fungal infections (HP:0002841) | 2.07816382 |
| 102 | Increased circulating renin level (HP:0000848) | 2.07484483 |
| 103 | Dyschromatopsia (HP:0007641) | 2.06380373 |
| 104 | Multiple enchondromatosis (HP:0005701) | 2.05378414 |
| 105 | Trismus (HP:0000211) | 2.05303347 |
| 106 | Long clavicles (HP:0000890) | 2.05291485 |
| 107 | Spontaneous hematomas (HP:0007420) | 2.03130044 |
| 108 | Hypoglycemic coma (HP:0001325) | 2.02000963 |
| 109 | Poikiloderma (HP:0001029) | 2.01838431 |
| 110 | Amaurosis fugax (HP:0100576) | 2.00142994 |
| 111 | Hematochezia (HP:0002573) | 1.99867827 |
| 112 | Pustule (HP:0200039) | 1.99543149 |
| 113 | Hypoplasia of the fovea (HP:0007750) | 1.99247623 |
| 114 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.99247623 |
| 115 | Proximal tubulopathy (HP:0000114) | 1.99024101 |
| 116 | Exercise intolerance (HP:0003546) | 1.98203736 |
| 117 | Constricted visual fields (HP:0001133) | 1.97459172 |
| 118 | Abnormality of chloride homeostasis (HP:0011422) | 1.95651020 |
| 119 | Morphological abnormality of the inner ear (HP:0011390) | 1.95471833 |
| 120 | Atrioventricular block (HP:0001678) | 1.94706340 |
| 121 | Recurrent bacterial skin infections (HP:0005406) | 1.94413282 |
| 122 | Absent thumb (HP:0009777) | 1.94297051 |
| 123 | Progressive macrocephaly (HP:0004481) | 1.93472616 |
| 124 | Gonadal dysgenesis (HP:0000133) | 1.93057732 |
| 125 | Asplenia (HP:0001746) | 1.91671680 |
| 126 | Abnormality of eosinophils (HP:0001879) | 1.91299161 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.90743230 |
| 128 | Vacuolated lymphocytes (HP:0001922) | 1.90679524 |
| 129 | Increased muscle lipid content (HP:0009058) | 1.89947581 |
| 130 | Metaphyseal dysplasia (HP:0100255) | 1.89769390 |
| 131 | Palmar hyperkeratosis (HP:0010765) | 1.89400587 |
| 132 | Hyperventilation (HP:0002883) | 1.88831836 |
| 133 | Selective tooth agenesis (HP:0001592) | 1.88786280 |
| 134 | Panhypogammaglobulinemia (HP:0003139) | 1.88430332 |
| 135 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88142040 |
| 136 | Agnosia (HP:0010524) | 1.87917709 |
| 137 | Bundle branch block (HP:0011710) | 1.87687314 |
| 138 | Hemoptysis (HP:0002105) | 1.87484148 |
| 139 | Hypokalemic alkalosis (HP:0001949) | 1.87237859 |
| 140 | Hyperactive renin-angiotensin system (HP:0000841) | 1.86551468 |
| 141 | Short middle phalanx of the 5th finger (HP:0004220) | 1.86396121 |
| 142 | Bone marrow hypocellularity (HP:0005528) | 1.86120131 |
| 143 | Acute encephalopathy (HP:0006846) | 1.85342173 |
| 144 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83895850 |
| 145 | Meckel diverticulum (HP:0002245) | 1.83171853 |
| 146 | IgG deficiency (HP:0004315) | 1.82971189 |
| 147 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.82396377 |
| 148 | Severe visual impairment (HP:0001141) | 1.81247834 |
| 149 | Pancytopenia (HP:0001876) | 1.80556663 |
| 150 | Triphalangeal thumb (HP:0001199) | 1.79859674 |
| 151 | Palmoplantar hyperkeratosis (HP:0000972) | 1.79369546 |
| 152 | Cystic hygroma (HP:0000476) | 1.79364080 |
| 153 | Abnormality of T cells (HP:0002843) | 1.79288313 |
| 154 | Poor head control (HP:0002421) | 1.79215530 |
| 155 | Fair hair (HP:0002286) | 1.78405093 |
| 156 | Systemic lupus erythematosus (HP:0002725) | 1.77814028 |
| 157 | Squamous cell carcinoma (HP:0002860) | 1.76324355 |
| 158 | Abnormality of the ileum (HP:0001549) | 1.76155654 |
| 159 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75982565 |
| 160 | Glossoptosis (HP:0000162) | 1.74912352 |
| 161 | Abnormality of salivation (HP:0100755) | 1.74465467 |
| 162 | Periodontitis (HP:0000704) | 1.74302987 |
| 163 | Cellular immunodeficiency (HP:0005374) | 1.74069637 |
| 164 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.73858502 |
| 165 | Depressed nasal ridge (HP:0000457) | 1.73491428 |
| 166 | Ventricular fibrillation (HP:0001663) | 1.72711700 |
| 167 | Hamartoma of the eye (HP:0010568) | 1.72592116 |
| 168 | Severe combined immunodeficiency (HP:0004430) | 1.72132140 |
| 169 | Entropion (HP:0000621) | 1.71225856 |
| 170 | Popliteal pterygium (HP:0009756) | 1.70832740 |
| 171 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70682605 |
| 172 | Obstructive lung disease (HP:0006536) | 1.70682605 |
| 173 | Abnormal trabecular bone morphology (HP:0100671) | 1.70402907 |
| 174 | Amniotic constriction ring (HP:0009775) | 1.69991645 |
| 175 | Abnormality of placental membranes (HP:0011409) | 1.69991645 |
| 176 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69781501 |
| 177 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.68663547 |
| 178 | Neoplasm of the rectum (HP:0100743) | 1.68054113 |
| 179 | Syncope (HP:0001279) | 1.67049744 |
| 180 | Widely spaced teeth (HP:0000687) | 1.66713520 |
| 181 | Meningitis (HP:0001287) | 1.66655818 |
| 182 | Orchitis (HP:0100796) | 1.66077850 |
| 183 | Nemaline bodies (HP:0003798) | 1.65825281 |
| 184 | Abnormality of the fovea (HP:0000493) | 1.64797008 |
| 185 | Cheilitis (HP:0100825) | 1.64470353 |
| 186 | Recurrent bronchitis (HP:0002837) | 1.64249886 |
| 187 | Missing ribs (HP:0000921) | 1.64241269 |
| 188 | Petechiae (HP:0000967) | 1.61558008 |
| 189 | Cellulitis (HP:0100658) | 1.60896023 |
| 190 | Abnormal protein glycosylation (HP:0012346) | 1.60452013 |
| 191 | Abnormal glycosylation (HP:0012345) | 1.60452013 |
| 192 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.60452013 |
| 193 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.60452013 |
| 194 | Cutaneous melanoma (HP:0012056) | 1.60301040 |
| 195 | Sparse scalp hair (HP:0002209) | 1.58787946 |
| 196 | Dry hair (HP:0011359) | 1.58039101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.22283511 |
| 2 | STK16 | 2.98992130 |
| 3 | TAOK3 | 2.73691762 |
| 4 | WEE1 | 2.69192347 |
| 5 | PASK | 2.56572104 |
| 6 | MST4 | 2.48598261 |
| 7 | BUB1 | 2.42487972 |
| 8 | PIM2 | 2.20247440 |
| 9 | MAP3K12 | 2.14139325 |
| 10 | RPS6KB2 | 2.10268076 |
| 11 | VRK1 | 2.07960007 |
| 12 | STK24 | 2.07776675 |
| 13 | SRPK1 | 2.01543396 |
| 14 | MAP3K2 | 1.98697329 |
| 15 | MAP4K2 | 1.95017284 |
| 16 | RPS6KA4 | 1.94922232 |
| 17 | EIF2AK1 | 1.92622499 |
| 18 | CDC7 | 1.92169801 |
| 19 | TESK2 | 1.84166797 |
| 20 | TGFBR1 | 1.81666310 |
| 21 | LRRK2 | 1.65016972 |
| 22 | TEC | 1.64894556 |
| 23 | EIF2AK3 | 1.61725606 |
| 24 | BRSK2 | 1.57862029 |
| 25 | STK39 | 1.56706687 |
| 26 | OXSR1 | 1.54025490 |
| 27 | MAP4K1 | 1.52877654 |
| 28 | TESK1 | 1.52675308 |
| 29 | ERBB3 | 1.52322728 |
| 30 | PINK1 | 1.51363756 |
| 31 | TLK1 | 1.51169008 |
| 32 | ACVR1B | 1.50809290 |
| 33 | BTK | 1.49230350 |
| 34 | MKNK1 | 1.48856659 |
| 35 | NUAK1 | 1.45685827 |
| 36 | STK10 | 1.43968437 |
| 37 | BMPR2 | 1.43325073 |
| 38 | FES | 1.42762972 |
| 39 | IRAK4 | 1.40981586 |
| 40 | CAMKK2 | 1.40916495 |
| 41 | PAK4 | 1.39952821 |
| 42 | RIPK4 | 1.39546571 |
| 43 | AURKB | 1.34342358 |
| 44 | JAK1 | 1.31996447 |
| 45 | FLT3 | 1.30323420 |
| 46 | BRD4 | 1.29580670 |
| 47 | TSSK6 | 1.29146742 |
| 48 | SCYL2 | 1.29119655 |
| 49 | MATK | 1.27815110 |
| 50 | LIMK1 | 1.24362384 |
| 51 | ILK | 1.22731311 |
| 52 | PLK4 | 1.22244898 |
| 53 | SGK2 | 1.21791062 |
| 54 | DYRK3 | 1.21613732 |
| 55 | STK38L | 1.20684828 |
| 56 | KDR | 1.20672981 |
| 57 | TNIK | 1.19837471 |
| 58 | TXK | 1.18233118 |
| 59 | FGFR3 | 1.17828069 |
| 60 | BLK | 1.14741641 |
| 61 | STK3 | 1.11671000 |
| 62 | MAP3K14 | 1.10554170 |
| 63 | EPHA2 | 1.10316342 |
| 64 | MAPK7 | 1.09245640 |
| 65 | PIM1 | 1.07898537 |
| 66 | NEK6 | 1.07690571 |
| 67 | MAPK12 | 1.07005020 |
| 68 | PBK | 1.06000405 |
| 69 | EEF2K | 1.04764837 |
| 70 | PLK1 | 1.01494907 |
| 71 | MAP2K6 | 0.99875053 |
| 72 | CASK | 0.98651805 |
| 73 | CDK7 | 0.97449779 |
| 74 | NME1 | 0.97300024 |
| 75 | ZAP70 | 0.96760783 |
| 76 | AKT3 | 0.95498769 |
| 77 | NEK1 | 0.93237752 |
| 78 | NEK9 | 0.93209564 |
| 79 | PLK3 | 0.92877913 |
| 80 | YES1 | 0.92791314 |
| 81 | CDK3 | 0.92578814 |
| 82 | NEK2 | 0.92359630 |
| 83 | MAP3K8 | 0.92291352 |
| 84 | LATS1 | 0.91820860 |
| 85 | MKNK2 | 0.91650813 |
| 86 | ZAK | 0.91393850 |
| 87 | ATR | 0.89331565 |
| 88 | EIF2AK2 | 0.88423026 |
| 89 | EPHA4 | 0.87669771 |
| 90 | BCKDK | 0.87331865 |
| 91 | IRAK3 | 0.87280982 |
| 92 | DAPK2 | 0.85523291 |
| 93 | MAP2K3 | 0.85375954 |
| 94 | STK4 | 0.84532285 |
| 95 | CSF1R | 0.83658286 |
| 96 | CCNB1 | 0.83482055 |
| 97 | PIK3CA | 0.83283957 |
| 98 | TTK | 0.80878818 |
| 99 | MAP3K6 | 0.77911474 |
| 100 | SIK3 | 0.76962129 |
| 101 | DMPK | 0.75316986 |
| 102 | TRPM7 | 0.74346726 |
| 103 | MAPKAPK3 | 0.74198838 |
| 104 | CLK1 | 0.72905678 |
| 105 | CDK6 | 0.72860968 |
| 106 | WNK1 | 0.72199944 |
| 107 | HCK | 0.71949088 |
| 108 | ITK | 0.71563852 |
| 109 | NLK | 0.71546438 |
| 110 | PRKCQ | 0.70485832 |
| 111 | TIE1 | 0.70112690 |
| 112 | TYK2 | 0.68769769 |
| 113 | PRKG2 | 0.66552757 |
| 114 | SGK1 | 0.66139781 |
| 115 | TGFBR2 | 0.65601064 |
| 116 | CDK8 | 0.65272770 |
| 117 | PAK3 | 0.64750295 |
| 118 | PRKCE | 0.64006873 |
| 119 | BMPR1B | 0.63678087 |
| 120 | CDK4 | 0.63494892 |
| 121 | CSNK2A1 | 0.63247890 |
| 122 | CSNK2A2 | 0.63205395 |
| 123 | KIT | 0.62087234 |
| 124 | PDK2 | 0.61923050 |
| 125 | ERN1 | 0.61795165 |
| 126 | RPS6KB1 | 0.60907466 |
| 127 | JAK2 | 0.60349734 |
| 128 | FGFR2 | 0.59933314 |
| 129 | JAK3 | 0.59107595 |
| 130 | IKBKB | 0.58973523 |
| 131 | CSK | 0.58486170 |
| 132 | AURKA | 0.58365932 |
| 133 | GRK6 | 0.57662856 |
| 134 | SYK | 0.57590273 |
| 135 | WNK3 | 0.57455387 |
| 136 | TBK1 | 0.57274566 |
| 137 | MYLK | 0.56409068 |
| 138 | PRKG1 | 0.55947769 |
| 139 | CSNK1G2 | 0.54918839 |
| 140 | PRKAA2 | 0.54718159 |
| 141 | SGK3 | 0.54376361 |
| 142 | IRAK1 | 0.53620373 |
| 143 | MAP3K5 | 0.53359253 |
| 144 | MAP3K3 | 0.52963972 |
| 145 | PRKCI | 0.52822831 |
| 146 | MAP2K4 | 0.52704788 |
| 147 | DYRK2 | 0.51958480 |
| 148 | PIK3CG | 0.51936369 |
| 149 | RPS6KA5 | 0.51620230 |
| 150 | LYN | 0.50350736 |
| 151 | MAP3K10 | 0.50164099 |
| 152 | LCK | 0.49811727 |
| 153 | CSNK1G1 | 0.49157792 |
| 154 | BRSK1 | 0.48683773 |
| 155 | PAK1 | 0.48587459 |
| 156 | IGF1R | 0.48392165 |
| 157 | FRK | 0.47398031 |
| 158 | RPS6KA6 | 0.47118911 |
| 159 | ADRBK2 | 0.47013114 |
| 160 | SGK223 | 0.46506706 |
| 161 | SGK494 | 0.46506706 |
| 162 | IKBKE | 0.45226976 |
| 163 | CDK19 | 0.44686660 |
| 164 | RPS6KL1 | 0.44025687 |
| 165 | RPS6KC1 | 0.44025687 |
| 166 | OBSCN | 0.43681675 |
| 167 | PAK2 | 0.43632738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.45291595 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.22590502 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.74379137 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.62034078 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.41942769 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.78913035 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76225942 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.75056703 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54728373 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38782907 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.36948047 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.31993204 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.30706201 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.30371180 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.21478976 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 2.19708560 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 2.14225940 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.13215670 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 2.03667344 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.97378607 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.90528198 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.85160657 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74732424 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71559102 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.67111654 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63059368 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62925133 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.60098905 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.60021412 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.57636064 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.53160651 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.50724175 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48927618 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.47215517 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45214573 |
| 36 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.40351254 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.37507801 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.37406128 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31525632 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27308289 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24993291 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23029311 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20506982 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17981492 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16589151 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14729078 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12031450 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10854951 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 1.07962582 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.07448191 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06024509 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04809080 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04155831 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 1.04148157 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03470045 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03181480 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02248916 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00572680 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99937199 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99305333 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98422884 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.97638853 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94897677 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.92777333 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.92254224 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91456373 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90816313 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88957429 |
| 69 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88579058 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88316048 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86515724 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.84353406 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84229673 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84068931 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83867350 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82147859 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82133088 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81772672 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79021374 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78448060 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78241027 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77626281 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77189813 |
| 84 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77079898 |
| 85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77040511 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76494183 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76338703 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76170866 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.75055400 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74960824 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74769785 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74623891 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73517958 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73285509 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73032731 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71599350 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71228513 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70493702 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69897894 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69844072 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69262916 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68762769 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68615891 |
| 104 | Long-term depression_Homo sapiens_hsa04730 | 0.68571455 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.67418982 |
| 106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67377449 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67224421 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66821282 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.66409584 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66186282 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66141724 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65886523 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63898817 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61046613 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59754100 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.58220299 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58078885 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57177441 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56818477 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56813180 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.56697810 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55141564 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54039070 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53009981 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52590728 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.52512728 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51833602 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50945256 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50243494 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49633732 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48621369 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48604754 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48212341 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47968307 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47620004 |
| 136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47564139 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.47320194 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47076286 |
| 139 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46708045 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46663662 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45649073 |
| 142 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44827056 |
| 143 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44412694 |
| 144 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43246093 |
| 145 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42929513 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41640736 |
| 147 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40775344 |
| 148 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40068277 |
| 149 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38771424 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38732030 |
| 151 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38665895 |
| 152 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35565564 |
| 153 | Influenza A_Homo sapiens_hsa05164 | 0.35324488 |
| 154 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34973768 |
| 155 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34728316 |
| 156 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34288751 |
| 157 | Bladder cancer_Homo sapiens_hsa05219 | 0.30871133 |
| 158 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30843590 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30637149 |
| 160 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30512497 |
| 161 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30007480 |
| 162 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28140411 |
| 163 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27725548 |
| 164 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.26703625 |
| 165 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26181249 |
| 166 | Allograft rejection_Homo sapiens_hsa05330 | 0.25111527 |
| 167 | Salmonella infection_Homo sapiens_hsa05132 | 0.24055131 |
| 168 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23542387 |
| 169 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.23305278 |
| 170 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22933171 |
| 171 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.22529851 |
| 172 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21281912 |
| 173 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.19643655 |
| 174 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19526945 |
| 175 | Malaria_Homo sapiens_hsa05144 | 0.18974714 |

